CORMORANT ASSET MANAGEMENT, LLC Information

100 HIGH STREET, SUITE 1105, BOSTON, Massachusetts, 02110, (617) 848-3429

Report Date: 12/31/2014

Position Statistics

Total Positions 75
New Positions 11
Increased Positions 27
Decreased Positions 16
Positions with Activity 43
Sold Out Positions 6
Total Mkt Value (in $ millions) 707

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 15.99%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 57.13%
Services
Technology
Transportation
Utilities

75 Positions as of 12/31/2014

Company Class Value of Shares ($1,000s) ▲ Change in Value ($1,000s) Change (%) Shares Held
AGIOS PHARMACEUTICALS INC COM -9,613 Sold Out 0
ALNYLAM PHARMACEUTICALS INC COM -5,358 Sold Out 0
ARROWHEAD RESH CORP COM NEW -6,246 Sold Out 0
CLOVIS ONCOLOGY INC COM -5,737 Sold Out 0
JAZZ PHARMACEUTICALS PLC SHS USD -18,323 Sold Out 0
ZS PHARMA INC COM -2,083 Sold Out 0
SAGE THERAPEUTICS INC COM 58 -521 (90) 1,000
CELSUS THERAPEUTICS PLC SPONSORED ADR NE 210 39 22.70 300,000
CELLECTAR BIOSCIENCES INC WT EXP 081919 424 New 530,000
NEVRO CORP COM 466 466 New 10,000
EPIRUS BIOPHARMACEUTICALS INC COM 503 503 New 75,000
PTC THERAPEUTICS INC COM 608 -6,997 (92) 10,000
MINERVA NEUROSCIENCES INC COM 893 New 175,000
VERACYTE INC COM 895 895 New 100,200
GALECTIN THERAPEUTICS INC COM NEW 914 -406 (30.73) 312,000
AKEBIA THERAPEUTICS INC COM 935 -2,233 (70.5) 118,000
SCYNEXIS INC COM 941 New 100,000
APPLIED GENETIC TECHNOL CORP COM 1,016 New 60,600
BELLICUM PHARMACEUTICALS INC COM 1,385 1,385 New 60,000
CELLECTAR BIOSCIENCES INC COM NEW 1,617 New 530,000


Create your free portfolio